Echosens SA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Echosens SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11409
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Echosens SA (Echosens), a subsidiary of Inner Mongolia Free Han & Mongolia Pharmaceutical Co Ltd, is a medical device company that offers diagnostic products. The company designs and develops diagnosis solutions for patients with chronic liver diseases. It offers fibrometer, fibroscan, fibroview and fibrovet, among others. Its fibroscan is a technique that measures stiffness at a defined and controlled frequency. Echosens’ fibrometer is blood tests combining several biological markers providing fibrosis score and fibrosis classification. The company’s fibroview software provides optimize clinical processes and enable connectivity between devices and hospital information systems. Echosens is headquartered in Paris, France.

Echosens SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Echosens SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Echosens SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Echosens SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Echosens SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Echosens SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Echosens SA, Medical Equipment, Deal Details 10
Venture Financing 10
Echosens Raises USD32.7 Million in Venture Financing 10
Private Equity 11
Astorg Partners Acquires Stake in Echosens from Cathay Capital 11
Astorg Partners Acquires Stake in Echosens from Orbimed Advisors 13
Equity Offering 15
Echosens Postpones IPO 15
Acquisition 16
Echosens Acquires BioLiveScale, Provider Of Biomarkers For Liver Diseases 16
Echosens SA – Key Competitors 17
Echosens SA – Key Employees 18
Echosens SA – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Echosens SA, Medical Equipment, Key Facts 2
Echosens SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Echosens SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Echosens SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Echosens SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Echosens SA, Deals By Market, 2012 to YTD 2018 8
Echosens SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Echosens Raises USD32.7 Million in Venture Financing 10
Astorg Partners Acquires Stake in Echosens from Cathay Capital 11
Astorg Partners Acquires Stake in Echosens from Orbimed Advisors 13
Echosens Postpones IPO 15
Echosens Acquires BioLiveScale, Provider Of Biomarkers For Liver Diseases 16
Echosens SA, Key Competitors 17
Echosens SA, Key Employees 18

List of Figures
Echosens SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Echosens SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Echosens SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Echosens SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Echosens SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Echosens SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Echosens SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Echosens SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Echosens SA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anadarko Petroleum Corp (APC):石油・ガス:M&Aディール及び事業提携情報
    Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, and natural gas liquids (NGLs) from its assets. It also involves in gathering, processing, treating, …
  • Zurich Insurance Group Ltd:企業のM&A・事業提携・投資動向
    Zurich Insurance Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zurich Insurance Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Vanda Pharmaceuticals Inc (VNDA):企業の財務・戦略的SWOT分析
    Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Philogen SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Philogen SpA (Philogen) is a biotechnology company that develops biopharmaceuticals for the treatment of angiogenesis-related disorders. The company provides pipeline products such as darleukin, teleukin, fibromun, radretumab, dekavil and tetravil, among others. It offers technologies such a …
  • Ali Baba:企業の戦略・SWOT・財務情報
    Ali Baba - Strategy, SWOT and Corporate Finance Report Summary Ali Baba - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Compagnie Des Alpes Sa:企業の戦略・SWOT・財務分析
    Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report Summary Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cytori Therapeutics Inc (CYTX):医療機器:M&Aディール及び事業提携情報
    Summary Cytori Therapeutics Inc (Cytori) is a clinical stage cell therapy company. It develops cell therapies from autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. The company has two therapeutic …
  • Sumitomo Heavy Industries Ltd (6302):企業の財務・戦略的SWOT分析
    Sumitomo Heavy Industries Ltd (6302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Accord Financial Corp. (ACD):企業の財務・戦略的SWOT分析
    Accord Financial Corp. (ACD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Smiths Group plc:企業の戦略・SWOT・財務情報
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dufry AG (DUFN):企業の財務・戦略的SWOT分析
    Dufry AG (DUFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The National Commercial Bank:企業の戦略・SWOT・財務情報
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mears Group PLC (MER):企業の財務・戦略的SWOT分析
    Summary Mears Group PLC (Mears) is a housing and social care provider. The company offers repairs, rapid response and planned maintenance services for a portfolio of social homes. It provides housing services such as new homes, energy services, housing management, home improvement, branches, planned …
  • Oilex Ltd (OEX):企業の財務・戦略的SWOT分析
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Phoenix Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Nishimatsu Construction Co Ltd (1820):企業の財務・戦略的SWOT分析
    Nishimatsu Construction Co Ltd (1820) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • AEON Credit Service (Asia) Co., Ltd.:企業の戦略・SWOT・財務情報
    AEON Credit Service (Asia) Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AEON Credit Service (Asia) Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • GVK Power and Infrastructure Ltd (GVKPIL):企業の財務・戦略的SWOT分析
    GVK Power and Infrastructure Ltd (GVKPIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Swedish Orphan Biovitrum AB (SOBI):製薬・医療:M&Aディール及び事業提携情報
    Summary Swedish Orphan Biovitrum AB (Sobi), formerly Biovitrum AB, is an integrated biopharmaceutical company that focuses on the development of products for the treatment of rare diseases. The company specializes in biotechnology with prime capabilities in protein biochemistry and biologics manufac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆